D.E. Shaw & Co’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.84M Sell
310,610
-47,647
-13% -$400K ﹤0.01% 2640
2025
Q4
$2.67M Buy
358,257
+169,365
+90% +$1.22M ﹤0.01% 2816
2025
Q3
$1.26M Buy
188,892
+118,450
+168% +$822K ﹤0.01% 3306
2025
Q2
$466K Sell
70,442
-97,309
-58% -$690K ﹤0.01% 3672
2025
Q1
$1.53M Buy
167,751
+7,095
+4% +$70.9K ﹤0.01% 2802
2024
Q4
$1.69M Sell
160,656
-160,974
-50% -$1.9M ﹤0.01% 2850
2024
Q3
$3.84M Buy
321,630
+124,455
+63% +$1.08M 0.01% 2162
2024
Q2
$1.13M Buy
+197,175
New +$1.08M ﹤0.01% 3105
2024
Q1
Sell
-35,910
Closed -$189K 4371
2023
Q4
$189K Buy
+35,910
New +$142K ﹤0.01% 3892
2023
Q2
Sell
-18,300
Closed -$19.6K 4271
2023
Q1
$19.6K Buy
18,300
+5,700
+45% +$10.9K ﹤0.01% 4147
2022
Q4
$32.9K Buy
+12,600
New +$55K ﹤0.01% 4472
2021
Q4
Sell
-15,024
Closed -$213K 5426
2021
Q3
$213K Buy
+15,024
New +$231K ﹤0.01% 4538

Other funds holding BVS